SMAD2 and hepatocellular carcinoma: This compound was able to inhibit the mobility and invasiveness of HCC cells with mitochondrial DNA depletion, as well as the expression of mesenchymal markers, TGFβ, the gene Snail, or the phosphorylation of SMAD2/SMAD3 [86].